yoshimoto taichiro

FacultyDepartmentofPathology,DivisionofIntegrativePathology
Job titleAssistant ProfessorWeb site

Profile

Research Areas

  • Basic medicine / Human pathology

Research Activities

Papers(paper)

  • Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad.
    Matsubara D, Kanai Y, Ishikawa S, Ohara S, Yoshimoto T, Sakatani T, Oguni S, Tamura T, Kataoka H, Endo S, Murakami Y, Aburatani H, Fukayama M, Niki T
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 7 1872-1876 Dec. 2012
  • Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.
    Inoue T, Matsuura K, Yoshimoto T, Nguyen LT, Tsukamoto Y, Nakada C, Hijiya N, Narimatsu T, Nomura T, Sato F, Nagashima Y, Kashima K, Hatakeyama S, Ohyama C, Numakura K, Habuchi T, Nakagawa M, Seto M, Mimata H, Moriyama M
    Cancer science 103 569-576 Mar. 2012
  • Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma.
    Matsuura K, Nakada C, Mashio M, Narimatsu T, Yoshimoto T, Tanigawa M, Tsukamoto Y, Hijiya N, Takeuchi I, Nomura T, Sato F, Mimata H, Seto M, Moriyama M
    BMC cancer 11 523 Dec. 2011
  • [Case report; an autopsy case of Erdheim-Chester disease involving the lung and heart].
    Suzuki S, Matsuura T, Fukuda M, Take M, Kubo S, Yoshimoto T
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 100 3629-3633 Dec. 2011
  • Genome-wide microRNA expression profiling in renal cell carcinoma: significant downregulation of miR-141 and miR-200c.
    Taichiro Yoshimoto
    Journal of pathology 216 418-427 2008
  • High-resolution analysis of DNA copy number alterations and the gene expression in renal clear cell carcinoma.
    Taichiro Yoshimoto
    Journal of pathology 213 392-401 2007
Display all
Papers(paper)close
  • Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad.
    Matsubara D, Kanai Y, Ishikawa S, Ohara S, Yoshimoto T, Sakatani T, Oguni S, Tamura T, Kataoka H, Endo S, Murakami Y, Aburatani H, Fukayama M, Niki T
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 7 1872-1876 Dec. 2012
  • Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.
    Inoue T, Matsuura K, Yoshimoto T, Nguyen LT, Tsukamoto Y, Nakada C, Hijiya N, Narimatsu T, Nomura T, Sato F, Nagashima Y, Kashima K, Hatakeyama S, Ohyama C, Numakura K, Habuchi T, Nakagawa M, Seto M, Mimata H, Moriyama M
    Cancer science 103 569-576 Mar. 2012
  • Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma.
    Matsuura K, Nakada C, Mashio M, Narimatsu T, Yoshimoto T, Tanigawa M, Tsukamoto Y, Hijiya N, Takeuchi I, Nomura T, Sato F, Mimata H, Seto M, Moriyama M
    BMC cancer 11 523 Dec. 2011
  • [Case report; an autopsy case of Erdheim-Chester disease involving the lung and heart].
    Suzuki S, Matsuura T, Fukuda M, Take M, Kubo S, Yoshimoto T
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 100 3629-3633 Dec. 2011
  • Genome-wide microRNA expression profiling in renal cell carcinoma: significant downregulation of miR-141 and miR-200c.
    Taichiro Yoshimoto
    Journal of pathology 216 418-427 2008
  • High-resolution analysis of DNA copy number alterations and the gene expression in renal clear cell carcinoma.
    Taichiro Yoshimoto
    Journal of pathology 213 392-401 2007


Copyright c MEDIA FUSION Co.,Ltd. All rights reserved.